Gourni E

References (6)

Title : FAP-Inhibitor Homodimers with Engineered Linker-Spacer Units: Toward Optimized Radiopharmaceuticals - Kumar_2026_ACS.Omega_11_49001
Author(s) : Kumar N , Martin M , Bilinska A , Menendez E , De Meester I , Roesch F , Rominger A , Gourni E
Ref : ACS Omega , 11 :49001 , 2026
Abstract :
PubMedSearch : Kumar_2026_ACS.Omega_11_49001
PubMedID: 42662658

Title : Preclinical evaluation of DOTAGA.Glu.(FAPI)(2) and DO3A.Glu.(FAPI)(2) as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs - Bilinska_2026_Eur.J.Nucl.Med.Mol.Imaging_53_1887
Author(s) : Bilinska A , Kumar N , Gnesin S , Lappchen T , Menendez E , Martin M , Rosch F , Rominger A , Gourni E
Ref : Eur J Nucl Med Mol Imaging , 53 :1887 , 2026
Abstract :
PubMedSearch : Bilinska_2026_Eur.J.Nucl.Med.Mol.Imaging_53_1887
PubMedID: 41105225

Title : Homomultimeric FAP Inhibitor-Based Radioligands for Cancer Theranostics: Design Principles, Structure-Function Relationships, and Preclinical Performance - Wu_2026_Molecules_31_2124
Author(s) : Wu Z , Gourni E , Ballal S , Van der Veken P , Roesch F
Ref : Molecules , 31 : , 2026
Abstract :
PubMedSearch : Wu_2026_Molecules_31_2124
PubMedID: 42357520

Title : Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the (68)Ga- and (177)Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)(2) - Lappchen_2024_Molecules_29_
Author(s) : Lappchen T , Bilinska A , Pilatis E , Menendez E , Imlimthan S , Moon ES , Afshar-Oromieh A , Rosch F , Rominger A , Gourni E
Ref : Molecules , 29 : , 2024
Abstract :
PubMedSearch : Lappchen_2024_Molecules_29_
PubMedID: 38999044

Title : Translational assessment of a DATA-functionalized FAP inhibitor with facile (68)Ga-labeling at room temperature - Escudero-Castellanos_2023_Eur.J.Nucl.Med.Mol.Imaging_50_3202
Author(s) : Escudero-Castellanos A , Kurth J , Imlimthan S , Menendez E , Pilatis E , Moon ES , Lappchen T , Rathke H , Schwarzenbock SM , Krause BJ , Rosch F , Rominger A , Gourni E
Ref : Eur J Nucl Med Mol Imaging , 50 :3202 , 2023
Abstract :
PubMedSearch : Escudero-Castellanos_2023_Eur.J.Nucl.Med.Mol.Imaging_50_3202
PubMedID: 37284857

Title : New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress - Imlimthan_2021_Pharmaceuticals.(Basel)_14_
Author(s) : Imlimthan S , Moon ES , Rathke H , Afshar-Oromieh A , Rosch F , Rominger A , Gourni E
Ref : Pharmaceuticals (Basel) , 14 : , 2021
Abstract :
PubMedSearch : Imlimthan_2021_Pharmaceuticals.(Basel)_14_
PubMedID: 34681246
Gene_locus related to this paper: human-FAP